Quantcast

Garden State Times

Thursday, November 21, 2024

FDA conducted second lowest number of inspections on Drugs companies in New Jersey during Q4 2023

Webp ishuwpt6uyanzpnvvfpnzrwi0yoq

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website

In the fourth quarter of 2023, three Drugs companies received three FDA inspections in New Jersey, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in New Jersey, equalling 5.2% of all inspections in the fourth quarter of 2023.

Of all the New Jersey companies involved in the Drugs sector, Hit Promo, LLC received the most citations from the FDA in the fourth quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in New Jersey During Q4 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Blood and Blood Products51--
Drug Quality Assurance--3--
Food Composition, Standards, Labeling and Econ10----
Foodborne Biological Hazards3313--
Human Cellular, Tissue, and Gene Therapies2----
Monitoring of Marketed Animal Drugs, Feed, and Devices1----
Tobacco Post-Market Activities1----

MORE NEWS